Shin Murai

Shin Murai

Auto-generated profile, based on publicly available information

Shin Murai

Faculty of Medicine, Department of Biochemistry, Toho University, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMShin Murai
Shin Murai
YYYoshifumi Yamaguchi
Yoshifumi Yamaguchi
YSYoshitaka Shirasaki
Yoshitaka Shirasaki
MYMai Yamagishi
Mai Yamagishi
RSRyodai Shindo
Ryodai Shindo
HNHiroyasu Nakano
Hiroyasu Nakano
Necroptosis is a regulated form of necrosis that depends on receptor-interacting protein kinase (RIPK)3 and mixed lineage kinase domain-like (MLKL). While danger-associated molecular pattern (DAMP)s are involved in various pathological conditions and released from dead cells, the underlying mechanisms are not fully understood. Here we develop a fluorescence resonance energy transfer (FRET) biosensor, termed SMART (a sensor for MLKL activation by RIPK3 based on FRET). SMART is composed of a fragment of MLKL and monitors necroptosis, but not apoptosis or necrosis. Mechanistically, SMART monitors plasma membrane translocation of oligomerized MLKL, which is induced by RIPK3 or mutational activation. SMART in combination with imaging of the release of nuclear DAMPs and Live-Cell Imaging for Secretion activity (LCI-S) reveals two different modes of the release of High Mobility Group Box 1 from necroptotic cells. Thus, SMART and LCI-S uncover novel regulation of the release of DAMPs during necroptosis.

1 June 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SMSanae Miyake
Sanae Miyake
SMShin Murai
Shin Murai
SKSoichiro Kakuta
Soichiro Kakuta
YUYasuo Uchiyama
Yasuo Uchiyama
HNHiroyasu Nakano
Hiroyasu Nakano

23 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YIYuka Inaba
Yuka Inaba
EHEmi Hashiuchi
Emi Hashiuchi
HWHitoshi Watanabe
Hitoshi Watanabe
KKKumi Kimura
Kumi Kimura
YOYu Oshima
Yu Oshima
HIHiroshi Inoue
Hiroshi Inoue
Hepatocellular death increases with hepatic steatosis aggravation, although its regulation remains unclear. Here we show that hepatic steatosis aggravation shifts the hepatocellular death mode from apoptosis to necroptosis, causing increased hepatocellular death. Our results reveal that the transcription factor ATF3 acts as a master regulator in this shift by inducing expression of RIPK3, a regulator of necroptosis. In severe hepatic steatosis, after partial hepatectomy, hepatic ATF3-deficient or -overexpressing mice display decreased or increased RIPK3 expression and necroptosis, respectively. In cultured hepatocytes, ATF3 changes TNFα-dependent cell death mode from apoptosis to necroptosis, as revealed by live-cell imaging. In non-alcoholic steatohepatitis (NASH) mice, hepatic ATF3 deficiency suppresses RIPK3 expression and hepatocellular death. In human NASH, hepatocellular damage is correlated with the frequency of hepatocytes expressing ATF3 or RIPK3, which overlap frequently. ATF3-dependent RIPK3 induction, causing a modal shift of hepatocellular death, can be a therapeutic target for steatosis-induced liver damage, including NASH.

19 January 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
ONOsamu Nakabayashi
Osamu Nakabayashi
HTHirotaka Takahashi
Hirotaka Takahashi
KMKenta Moriwaki
Kenta Moriwaki
SKSachiko Komazawa-Sakon
Sachiko Komazawa-Sakon
FOFumiaki Ohtake
Fumiaki Ohtake
HNHiroyasu Nakano
Hiroyasu Nakano
Mind bomb 2 (MIB2) is an E3 ligase involved in Notch signalling and attenuates TNF-induced apoptosis through ubiquitylation of receptor-interacting protein kinase 1 (RIPK1) and cylindromatosis. Here we show that MIB2 bound and conjugated K48– and K63–linked polyubiquitin chains to a long-form of cellular FLICE-inhibitory protein (cFLIPL), a catalytically inactive homologue of caspase 8. Deletion of MIB2 did not impair the TNF-induced complex I formation that mediates NF-κB activation but significantly enhanced formation of cytosolic death-inducing signalling complex II. TNF-induced RIPK1 Ser166 phosphorylation, a hallmark of RIPK1 death-inducing activity, was enhanced in MIB2 knockout cells, as was RIPK1 kinase activity-dependent and -independent apoptosis. Moreover, RIPK1 kinase activity-independent apoptosis was induced in cells expressing cFLIPL mutants lacking MIB2-dependent ubiquitylation. Together, these results suggest that MIB2 suppresses both RIPK1 kinase activity-dependent and -independent apoptosis, through suppression of RIPK1 kinase activity and ubiquitylation of cFLIPL, respectively.

1 May 2010 in Developmental Biology
Verified
Journal Article
Closed access
SMShin Murai
Shin Murai
PSPaula Stein
Paula Stein
MBMariano G. Buffone
Mariano G. Buffone
SYShigeru Yamashita
Shigeru Yamashita
RSRichard M. Schultz
Richard M. Schultz

1 April 2005 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
YTYuichi Tsuchiya
Yuichi Tsuchiya
SMShin Murai
Shin Murai
SYShigeru Yamashita
Shigeru Yamashita